The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor

Molecular and Cellular Biology

Volumn 20, Issue 11, 2000, Pages 3896-3905

  Soni, Payal ^a   Lakkis, Montaha ^a   Poy, Matthew N ^a   Fernström, Mats A ^a   Najjar, Sonia M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C; TYROSINE;

ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; DOWN REGULATION; LIGAND BINDING; LIVER CELL; MITOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

ANIMALS; CELL DIVISION; CELL LINE, TRANSFORMED; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; MITOGENS; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; RECOMBINANT FUSION PROTEINS; TYROSINE;

EID: 0034077136     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.11.3896-3905.2000     Document Type: Article

References (73)

1. Accili, D., J. Drago, E. J. Lee, M. D. Johnson, M. H. Cool, P. Salvatore, L. D. Asico, P. A. Jose, S. I. Taylor, and H. Westphal. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106-109.
2. Ando, A., K. Momomura, K. Tobe, R. Yamamoto-Honda, H. Sakura, Y. Tamori, Y. Kaburagi, O. Koshio, Y. Akanuma, Y. Yazaki et al. 1992. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine. J. Biol. Chem. 267: 12788-12796.
3. Araki, E., M. A. Lipes, M. E. Patti, J. C. Bruning, B. R. Haag, R. S. Johnson, and C. R. Kahn. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190.
4. Backer, J. M., G. G. Schroeder, C. R. Kahn, M. J. Myers, P. A. Wilden, D. A. Cahill, and M. F. White. 1992. Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. J. Biol. Chem. 267:1367-1374.
5. Baker, J., J. P. Liu, E. J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.
6. Beauchemin, N., et al. 1999. Nomenclature announcement. Exp. Cell Res. 252:243-249.
7. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889-5892.
8. Cheung, P. H., N. L. Thompson, K. Earley, O. Culic, D. Hixson, and S. H. Lin. 1993. Cell-CAM105 isoforms with different adhesion functions are co-expressed in adult rat tissues and during liver development. J. Biol. Chem. 268:6139-6146.
9. Craparo, A., T. J. O'Neill, and T. A. Gustafson. 1995. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor. J. Biol. Chem. 270:15639-15643.
10. Crews, C. M., and R. L. Erikson. 1993. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74:215-217.
11. Danielsen, A. G., F. Liu, Y. Hosomi, K. Shii, and R. A. Roth. 1995. Activation of protein kinase C alpha inhibits signaling by members of the insulin receptor family. J. Biol. Chem. 270:21600-21605.
12. Di Cola, G., M. H. Cool, and D. Accili. 1997. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J. Clin. Investig. 99: 2538-2544.
13. Edlund, M., and B. Öbrink. 1993. Evidence for calmodulin binding to the cytoplasmic domains of two C-CAM isoforms. FEBS Lett. 327:90-94.
14. Esposito, D. L., V. A. Blakesley, A. P. Koval, A. G. Scrimgeour, and D. LeRoith. 1997. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals. Endocrinology 138:2979-2988.
15. Faria, T. N., V. A. Blakesley, H. Kato, B. Stannard, D. LeRoith, and C. T. Roberts, Jr. 1994. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J. Biol. Chem. 269:13922-13928.
16. Formisano, P., S. M. Najjar, C. N. Gross, N. Philippe, F. Oriente, C. I. Kern-Buell, D. Accili, and P. Gorden. 1995. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J. Biol. Chem. 270:24073-24077.
17. Gale, N. W., S. Kaplan, E. J. Lowenstein, J. Schlessinger, and D. Bar-Sagi. 1993. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363:88-92.
18. Grønborg, M., B. S. Wulff, J. S. Rasmussen, T. Kjeldsen, and S. Gammeltoft. 1993. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J. Biol. Chem. 268:23435-23440.
19. Gustafson, T. A., W. He, A. Craparo, C. D. Schaub, and T. J. O'Neill. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15:2500-2508.
20. Hixson, D. C., K. D. McEntire, and B. Obrink. 1985. Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas. Cancer Res. 45:3742-3749.
21. Hsieh, J.-T., W. Luo, W. Song, Y. Wang, D. I. Kleinerman, N. T. Van, and S.-H. Lin. 1995. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 55:190-197.
22. Huber, M., L. Izzi, P. Grondin, C. Houde, T. Kunath, A. Veillette, and N. Beanchemin. 1999. The carboxy-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J. Biol. Chem. 274:335-344.
23. Kaburagi, Y., K. Momomura, H. R. Yamamoto, K. Tobe, Y. Tamori, H. Sakura, Y. Akanuma, Y. Yazaki, and T. Kadowaki. 1993. Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. J. Biol. Chem. 268:16610-16622.
24. Kato, H., T. N. Faria, B. Stannard, C. T. Roberts, Jr., and D. LeRoith. 1994. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol. Endocrinol. 8:40-50.
25. Kimura, M., and M. Ogihara. 1997. Proliferation of adult rat hepatocytes in primary culture induced by insulin is potentiated by cAMP-elevating agents. Eur. J. Pharmacol. 327:87-95.
26. Kleinerman, D. I., C. P. Dinney, W. W. Zhang, S. H. Lin, N. T. Van, and J. T. Hsieh. 1996. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res. 56:3431-3425.
27. Kleinerman, D. I., P. Troncoso, S. H. Lin, L. L. Pisters, E. R. Sherwood, T. Brooks, A. C. von Eschenbach, and J. T. Hsieh. 1995. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res. 55:1215-1220.
28. Lee, J., and P. F. Pilch. 1994. The insulin receptor: structure, function and signalling. Am. J. Physiol. 266:C319-C334.
29. Levy-Toledano, R., L. H. Caro, D. Accili, and S. I. Taylor. 1994. Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. EMBO J. 13:835-842.
30. Li, S., M. Resnicoff, and R. Baserga. 1996. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271:12254-12260.
31. Lin, S. H., and G. Guidotti. 1989. Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. J. Biol. Chem. 264:14408-14414.
32. Liu, J. P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
33. Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431-442.
34. Luo, W., K. Earley, V. Tantingco, D. C. Hixson, T. C. Liang, and S. H. Lin. 1998. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition. Oncogene 16:1141-1147.
35. Luo, W., C. G. Wood, K. Earley, M. C. Hung, and S. H. Lin. 1997. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Oncogene 14:1697-1704.
36. Maegawa, H., D. A. McClain, G. Freidenberg, J. M. Olefsky, M. Napier, T. Lipari, T. J. Dull, J. Lee, and A. Ullrich. 1988. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. J. Biol. Chem. 263:8912-8917.
37. Margolis, R. N., M. J. Schell, S. I. Taylor, and A. L. Hubbard. 1990. Hepatocyte plasma membrane ecto-ATPase (pp120/HA4) is a substrate for tyrosine kinase activity of the insulin receptor. Biochem. Biophys. Res. Commun. 166:562-566.
38. Morgan, D., K. Jarnagin, and R. Roth. 1986. Purification and characterization of the receptor for insulin-like growth factor 1. Biochemistry 25:5560-5564.
39. Murakami, M. S., and O. M. Rosen. 1991. The role of insulin receptor autophosphorylation in signal transduction. J. Biol. Chem. 266:22653-22660.
40. Najjar, S. M. 1998. pp120, a substrate of the insulin receptor tyrosine kinase, is associated with phosphatase activity. Biochem. Biophys. Res. Commun. 247:457-461.
41. Najjar, S. M., D. Accili, N. Philippe, J. Jernberg, R. Margolis, and S. I. Taylor. 1993. pp120/ecto-ATPase, an endogenous substrate of the insulin receptor tyrosine kinase, is expressed as two variably spliced isoforms. J. Biol. Chem. 268:1201-1206.
42. Najjar, S. M., V. A. Blakesley, S. Li Calzi, H. Kato, D. LeRoith, and C. V. Choice. 1997. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Biochemistry 36:6827-6834.
43. Najjar, S. M., C. V. Choice, P. Soni, C. M. Whitman, and M. N. Poy. 1998. Effect of pp120 on receptor-mediated insulin endocytosis is regulated by the juxtamembrane domain of the insulin receptor. J. Biol. Chem. 273:12923-12928.
44. Najjar, S. M., and R. E. Lewis. 1999. Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 230:41-45.
45. Najjar, S. M., N. Philippe, Y. Suzuki, G. A. Ignacio, P. Formisano, D. Accili, and S. I. Taylor. 1995. Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry 34:9341-9349.
46. Nédellec, P., G. S. Dveksler, E. Daniels, C. Turbide, B. Chow, A. A. Basile, K. V. Holmes, and N. Beauchemin. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:4525-4537.
47. Neumaier, M., S. Paululat, A. Chan, P. Matthaes, and C. Wagener. 1993. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. USA 90:10744-10748.
48. Pang, L., K. L. Milarski, M. Ohmichi, Y. Takata, J. M. Olefsky, and A. R. Saltiel. 1994. Mutation of two carboxyl-terminal tyrosines in the insulin receptor results in enhanced activation of mitogen-activated protein kinase. J. Biol. Chem. 269:10604-10608.
49. Pillay, T. S., J. Whittaker, R. Lammers, A. Ullrich, and K. Siddle. 1991. Multisite serine phosphorylation of the insulin and IGF-I receptors in transfected cells. FEBS Lett. 288:206-211.
50. Pronk, G. J., J. McGlade, G. Pelicci, T. Pawson, and J. I. Bos. 1993. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268:5748-5753.
51. Reusch, J. E., P. Hsieh, P. Bhuripanyo, K. Carel, J. W. Leitner, J. M. Olefsky, and B. Draznin. 1995. Insulin inhibits nuclear phosphatase activity: requirement for the C-terminal domain of the insulin receptor. Endocrinology 136:2464-2469.
52. Rosenberg, M., P. Nedellec, S. Jothy, D. Fleiszer, C. Turbide, and N. Beauchemin. 1993. The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues. Cancer Res. 53:4938-4945.
53. Rother, K. I., Y. Imai, M. Caruso, F. Beguinot, P. Formisano, and D. Accili. 1998. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol. Chem. 273:17491-17497.
54. Sasaoka, T., D. W. Rose, A. R. Saltiel, B. Draznin, and J. M. Olefsky. 1994. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-I, and epidermal growth factor. J. Biol. Chem. 269:13689-13694.
55. Shier, P., and V. M. Watt. 1992. Tissue-specific expression of the rat insulin receptor-related receptor gene. Mol. Endocrinol. 6:723-729.
56. Sippel, C. J., R. J. Fallon, and D. H. Perlmutter. 1994. Bile acid efflux mediated by the rat liver canalicular bile acid transport/ecto-ATPase protein requires serine 503 phosphorylation and is regulated by tyrosine 488 phosphorylation. J. Biol. Chem. 269:19539-19545.
57. Skolnik, E. Y., A. Batzer, N. Li, C. H. Lee, E. Lowenstein, M. Mohammadi, B. Margolis, and J. Schlessinger. 1993. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955.
58. Staubs, P. A., D. R. Reichart, A. R. Saltiel, K. L. Milarski, H. Maegawa, P. Berhanu, J. M. Olefsky, and B. L. Seely. 1994. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP. J. Biol. Chem. 269:27186-27192.
59. Takata, Y., N. J. Webster, and J. M. Olefsky. 1991. Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties. J. Biol. Chem. 266:9135-9139.
60. Takata, Y., N. J. G. Webster, and J. M. Olefsky. 1992. Intracellular signaling by a mutant human insulin receptor lacking the carboxyl-terminal tyrosine autophosphorylation sites. J. Biol. Chem. 267:9065-9070.
61. Tamemoto, H., T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, T. Hayakawa, Y. Terauchi, K. Ueki, Y. Kaburagi, S. Satoh et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372: 182-186.
62. Tartare, S., I. Mothe, A. Kowalski-Chauvel, J. P. Breittmayer, R. Ballotti, and E. Van Obberghen. 1994. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor. J. Biol. Chem. 269:11449-11455.
63. Thompson, N. L., S. H. Lin, M. A. Panzica, and D. C. Hixson. 1994. Cell CAM 105 isoform RNA expression is differentially regulated during rat liver regeneration and carcinogenesis. Pathobiology 62:209-220.
64. Turbide, C., T. Kunath, E. Daniels, and N. Beauchemin. 1997. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Cancer Res. 57:2781-2788.
65. Van Horn, D. J., M. G. Myers, Jr., and J. M. Backer. 1994. Direct activation of the phosphatidylinositol 3-kinase by the insulin receptor. J. Biol. Chem. 269:29-32.
66. White, M. F. 1998. The IRS-signalling system: a network of docking proteins that mediate insulin and interleukin signalling. Mol. Cell. Biochem. 182:3-11.
67. White, M. F., and C. R. Kahn. 1994. The insulin signaling system. J. Biol. Chem. 269:1-4.
68. White, M. F., J. N. Livingston, J. M. Backer, V. Lauris, T. J. Dull, A. Ullrich, and C. R. Kahn. 1988. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54:641-649.
69. Withers, D. J., J. S. Gutierrez, H. Towery, D. J. Burks, J. M. Ren, S. Previs, Y. Zhang, D. Bernal, S. Pons, G. I. Shulman, S. Bonner-Weir, and M. F. White. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904.
70. Xiao, S., D. W. Rose, T. Sasaoka, H. Maegawa, T. R. J. Burke, P. P. Roller, S. E. Shoelson, and J. M. Olefsky. 1994. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J. Biol. Chem. 269:21244-21248.
71. Yamamoto-Honda, R., T. Kadowaki, K. Momomura, K. Tobe, Y. Tamori, Y. Shibasaki, Y. Mori, Y. Kaburagi, O. Koshio, Y. Akanuma et al. 1993. Normal insulin receptor substrate-1 phosphorylation in autophosphorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin. J. Biol. Chem. 268:16859-16865.
72. Yamasaki, H., D. Prager, S. Gebremedhin, and S. Melmed. 1992. Human insulin-like growth factor I receptor 950 tyrosine is required for somatotroph growth factor signal transduction. J. Biol. Chem. 267:20953-20958.
73. Zhang, B., and R. A. Roth. 1992. The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities. J. Biol. Chem. 267:18320-18328.